DK0699687T3 - Fremgangsmåde til oprensning af rekombinant humant serumalbumin - Google Patents

Fremgangsmåde til oprensning af rekombinant humant serumalbumin

Info

Publication number
DK0699687T3
DK0699687T3 DK95113620T DK95113620T DK0699687T3 DK 0699687 T3 DK0699687 T3 DK 0699687T3 DK 95113620 T DK95113620 T DK 95113620T DK 95113620 T DK95113620 T DK 95113620T DK 0699687 T3 DK0699687 T3 DK 0699687T3
Authority
DK
Denmark
Prior art keywords
serum albumin
human serum
recombinant human
purifying recombinant
purifying
Prior art date
Application number
DK95113620T
Other languages
Danish (da)
English (en)
Inventor
Munehiro Noda
Akinori Sumi
Takao Ohmura
Kazumasa Yokoyama
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Application granted granted Critical
Publication of DK0699687T3 publication Critical patent/DK0699687T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK95113620T 1994-08-31 1995-08-30 Fremgangsmåde til oprensning af rekombinant humant serumalbumin DK0699687T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20770494 1994-08-31

Publications (1)

Publication Number Publication Date
DK0699687T3 true DK0699687T3 (da) 2004-04-26

Family

ID=16544190

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95113620T DK0699687T3 (da) 1994-08-31 1995-08-30 Fremgangsmåde til oprensning af rekombinant humant serumalbumin

Country Status (9)

Country Link
US (2) US5962649A (zh)
EP (1) EP0699687B1 (zh)
KR (1) KR100392021B1 (zh)
CN (2) CN1080301C (zh)
CA (1) CA2157219C (zh)
DE (1) DE69532492T2 (zh)
DK (1) DK0699687T3 (zh)
ES (1) ES2211889T3 (zh)
TW (1) TW363065B (zh)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728553A (en) 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
ES2211889T3 (es) * 1994-08-31 2004-07-16 Mitsubishi Pharma Corporation Procedimiento para la purificacion de albumina de suero recombinante.
WO1997031947A1 (en) * 1996-02-29 1997-09-04 Delta Biotechnology Limited High purity albumin production process
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
EP0947581A4 (en) * 1996-08-08 2004-07-28 Mitsubishi Pharma Corp CULTURAL MEDIUM AND ITS USE.
IL137649A (en) * 1998-02-18 2004-08-31 Genentech Inc Method of adsorption chromatography
US6830756B2 (en) * 1998-11-06 2004-12-14 Neomend, Inc. Systems, methods, and compositions for achieving closure of vascular puncture sites
US7351249B2 (en) * 1998-11-06 2008-04-01 Neomend, Inc. Systems, methods, and compositions for achieving closure of suture sites
US6899889B1 (en) * 1998-11-06 2005-05-31 Neomend, Inc. Biocompatible material composition adaptable to diverse therapeutic indications
US7279001B2 (en) * 1998-11-06 2007-10-09 Neomend, Inc. Systems, methods, and compositions for achieving closure of vascular puncture sites
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
EP1284287A4 (en) * 2000-05-10 2004-10-13 Mitsubishi Pharma Corp METHOD FOR PRODUCING A VIRUS VECTOR
US6787636B1 (en) 2000-07-14 2004-09-07 New Century Pharmaceuticals, Inc. Modified serum albumin with reduced affinity for nickel and copper
EP1175931A1 (en) * 2000-07-25 2002-01-30 Computer Cell Culture Center S.A. Integration of high cell density bioreactor operation with ultra fast on-line downstream processing
CZ303658B6 (cs) * 2001-02-01 2013-02-06 F. Hoffmann-La Roche Ag Zpusob rekombinantní produkce trypsinu
JP2002265383A (ja) * 2001-03-14 2002-09-18 Mitsubishi Pharma Corp インターフェロンα注射用液状製剤
DK1412384T3 (da) 2001-06-28 2008-04-28 Novo Nordisk As Stabil formulering af modificeret GLP-1
ITBO20010426A1 (it) 2001-07-06 2003-01-06 Alfa Wassermann Spa Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
KR20030007186A (ko) * 2001-07-17 2003-01-23 미쯔이카가쿠 가부시기가이샤 광 양이온성 경화가능 수지 조성물 및 그 용도
DE60333821D1 (de) * 2002-02-28 2010-09-30 Nipro Corp Stabilisierte albumin-zubereitungen
SE526227C2 (sv) 2002-05-15 2005-08-02 North China Pharmaceutical Group Metod för rening av rekombinant humant serumalbumin
WO2004048588A1 (en) * 2002-11-26 2004-06-10 Novo Nordisk A/S Process for purifying a fermentation-derived product
WO2004080575A1 (en) * 2003-03-12 2004-09-23 Fresenius Kabi Deutschland Gmbh Use of recombinant albumin in dialysis after liver failure
JP2007524592A (ja) 2003-06-03 2007-08-30 ノボ・ノルデイスク・エー／エス 安定化された薬学的ペプチド組成物
KR101308912B1 (ko) 2003-06-03 2013-09-23 노보 노르디스크 에이/에스 안정화된 약학적 펩티드 조성물
KR101243648B1 (ko) 2003-11-20 2013-03-14 노보 노르디스크 에이/에스 제조 및 주사 장치용에 최적인 프로필렌 글리콜 함유펩티드 제제
JP2005245269A (ja) * 2004-03-03 2005-09-15 Nipro Corp 血清アルブミン多量体を含む遺伝子組換え型蛋白質
DE602005022239D1 (de) * 2004-04-23 2010-08-19 Conjuchem Biotechnologies Inc Festphase zur Verwendung in einem Verfahren zur Reinigung von Albuminkonjugaten
EP2277912B1 (en) 2004-06-07 2016-09-28 Therapure Biopharma Inc. Isolation of plasma proteins
CN100374560C (zh) * 2004-08-27 2008-03-12 富岩 高效表达人血清白蛋白酵母菌株的构建及发酵纯化工艺
EP1789434B1 (en) 2004-08-31 2013-11-20 Novo Nordisk A/S Use of tris(hydroxymethyl) aminomethane for the stabilization of peptides, polypeptides and proteins
EP1817048B1 (en) 2004-11-12 2014-02-12 Novo Nordisk A/S Stable formulations of insulinoptropic peptides
CN1854306B (zh) * 2005-04-29 2011-07-27 华北制药集团新药研究开发有限责任公司 发酵生产重组人血清白蛋白hsa的方法
IL169230A (en) 2005-06-16 2012-03-29 Plasan Sasa Agricultural Cooperative Soc Ltd Ballistic armor
WO2007063129A2 (en) * 2005-12-02 2007-06-07 Novozymes A/S Insolation of peptides , polypeptides and proteins
JP4935242B2 (ja) * 2006-08-24 2012-05-23 ニプロ株式会社 脂肪酸を含有するｓ−ニトロソタンパク質とその製法
WO2008079302A2 (en) 2006-12-21 2008-07-03 Millipore Corporation Purification of proteins
US8569464B2 (en) 2006-12-21 2013-10-29 Emd Millipore Corporation Purification of proteins
BRPI0806601A2 (pt) * 2007-01-15 2011-09-06 Upfront Chromatography As produção de biocombustìvel e proteìna a partir de um material bruto
SG171446A1 (en) 2008-12-16 2011-07-28 Millipore Corp Stirred tank reactor and method
KR20120018827A (ko) 2009-02-20 2012-03-05 벤트리아 바이오사이언스 단백질의 조합을 함유하는 세포 배양 배지
CN102190722B (zh) * 2010-03-16 2014-03-26 上海欣瑞特生物医药技术有限公司 一种纯化重组人血白蛋白的方法
CN102892791B (zh) 2010-05-17 2017-05-17 Emd密理博公司 用于纯化生物分子的刺激响应性聚合物
CN102532254B (zh) * 2010-12-24 2015-06-24 武汉禾元生物科技股份有限公司 一种从水稻种子中分离纯化重组人血清白蛋白的方法
US20140235474A1 (en) 2011-06-24 2014-08-21 Sequenom, Inc. Methods and processes for non invasive assessment of a genetic variation
US10196681B2 (en) 2011-10-06 2019-02-05 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CA2850785C (en) 2011-10-06 2022-12-13 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9984198B2 (en) 2011-10-06 2018-05-29 Sequenom, Inc. Reducing sequence read count error in assessment of complex genetic variations
US10424394B2 (en) 2011-10-06 2019-09-24 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9367663B2 (en) 2011-10-06 2016-06-14 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
WO2013109981A1 (en) 2012-01-20 2013-07-25 Sequenom, Inc. Diagnostic processes that factor experimental conditions
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
US10482994B2 (en) 2012-10-04 2019-11-19 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
HUE061261T2 (hu) 2013-04-03 2023-05-28 Sequenom Inc Eljárások és folyamatok genetikai variánsok nem invazív értékelésére
EP3004383B1 (en) 2013-05-24 2019-04-24 Sequenom, Inc. Methods for non-invasive assessment of genetic variations using area-under-curve (auc) analysis
BR112015032031B1 (pt) 2013-06-21 2023-05-16 Sequenom, Inc Métodos e processos para avaliação não invasiva das variações genéticas
AU2014329493B2 (en) 2013-10-04 2020-09-03 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP3495496B1 (en) 2013-10-07 2020-11-25 Sequenom, Inc. Methods and processes for non-invasive assessment of chromosome alterations
US20160034640A1 (en) 2014-07-30 2016-02-04 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
PL3240798T3 (pl) 2015-01-01 2020-11-02 Shilpa Medicare Limited Nowy sposób skutecznego oczyszczania ludzkiej albuminy surowicy krwi
EP3491560A1 (en) 2016-07-27 2019-06-05 Sequenom, Inc. Genetic copy number alteration classifications
CA3207879A1 (en) 2017-01-24 2018-08-02 Sequenom, Inc. Methods and processes for assessment of genetic variations
HRP20240485T1 (hr) 2017-08-24 2024-07-05 Novo Nordisk A/S Pripravci glp-1 i njihova upotreba
US20230082544A1 (en) 2020-02-18 2023-03-16 Novo Nordisk A/S Pharmaceutical formulations
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US20230331772A1 (en) 2020-12-08 2023-10-19 Tonghua Anrate Biopharmaceutical Co., Ltd Method for purification of recombinant proteins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR570916A (zh) 1923-09-20 1924-05-09
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
KR830002718A (ko) 1980-04-22 1983-05-30 가와무라 요시부미 피라졸 유도체의 제조법
US4665192A (en) * 1984-03-19 1987-05-12 The Rockefeller University 2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole
FR2649991B2 (fr) * 1988-08-05 1994-03-04 Rhone Poulenc Sante Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
KR930702381A (ko) * 1991-07-12 1993-09-08 한스 발터 라벤 혈청 알부민의 정제방법
JPH07102147B2 (ja) * 1992-03-16 1995-11-08 株式会社ミドリ十字 ヒト血清アルブミンの着色抑制方法
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
ES2211889T3 (es) * 1994-08-31 2004-07-16 Mitsubishi Pharma Corporation Procedimiento para la purificacion de albumina de suero recombinante.

Also Published As

Publication number Publication date
DE69532492D1 (de) 2004-03-04
EP0699687A2 (en) 1996-03-06
CA2157219C (en) 2010-10-05
DE69532492T2 (de) 2004-12-02
US6617133B1 (en) 2003-09-09
CN1364643A (zh) 2002-08-21
US5962649A (en) 1999-10-05
CN1080301C (zh) 2002-03-06
CA2157219A1 (en) 1996-03-01
ES2211889T3 (es) 2004-07-16
TW363065B (en) 1999-07-01
CN1127299A (zh) 1996-07-24
KR960007612A (ko) 1996-03-22
EP0699687B1 (en) 2004-01-28
KR100392021B1 (ko) 2003-11-01
EP0699687A3 (en) 1996-12-18

Similar Documents

Publication Publication Date Title
DK0699687T3 (da) Fremgangsmåde til oprensning af rekombinant humant serumalbumin
DK0570916T3 (da) Fremgangsmåde til rensning af humant rekombinant serumalbumin
DK1036179T4 (da) Fremgangsmåde til fremstilling af polypeptider med egnet glycosilering
DE69515391D1 (de) Narkosesystem
DK1659178T3 (da) Fremgangsmåde til oprensning eller fremstilling af et MAGE-protein
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
NO974736L (no) Tilmalt dose-inhalator for salmeterol
DK0911416T3 (da) Fremgangsmåde til fremstilling af protein
DK0420007T3 (da) Fremgangsmåde til rensning af human serumalbumin
FI972030A0 (fi) Puhdistettuja papillomavirusproteiineja
NO980566D0 (no) Allergen-XCD32 fusjonsproteiner
FI970168A (fi) Peptidejä
DK1053217T3 (da) Fremgangsmåde til fremstilling af n-propanol
DK0656419T3 (da) Fremgangsmåde til højrensning af humant serumalbumin
DK0504823T3 (da) Fremgangsmåde til fremstilling af human serumalbumin
NO985571D0 (no) Legemiddel for autoimmunsykdommer
DK0591605T3 (da) Fremgangsmåde til undertrykkelse af farvning af humant serumalbumin
DK0658569T3 (da) Fremgangsmåde til affarvning af humant serumalbumin
DK0655503T3 (da) Fremgangsmåde til fremstilling af humant serumalbumin
DK0736605T3 (da) Fremgangsmåde til fremstilling af proteiner
DK13087D0 (da) Gensekvens til fremstilling af human serumalbumin i bacillus
DK281590A (da) Fremgangsmaade til regenereringsbehandling af overvejende lerbundet stoeberigammelsand
DE69500635D1 (de) Einpunkt Bondverfahren
DE69535511D1 (de) Zeitschaltersystem
DK0821697T3 (da) Fremgangsmåde til fremstilling af streptograminer